Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. Reference standards of Alendronic Acid API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alendronic Acid
Catalogue No.:PA 28 52000
CAS :
Molecular Formula : C4H13NO7P2
Molecular Weight : 249.10
Alendronic Acid Dimeric Anhydride
Catalogue No.:PA 28 52510
Molecular Formula : C8H22N2O12P4
Molecular Weight : 462.17
Alendronic Acid-d6 (Major)
Catalogue No.:PA STI 004590
Molecular Formula : C4H7D6NO7P2
Molecular Weight : 255.13
Alendronic Acid-d6 Sodium Salt Hydrate
Catalogue No.:PA STI 004600
Molecular Formula : C4H6D6NNaO7P2.(H2O)x
Molecular Weight : NA
2-Pyrrolidinylphosphonic Acid
Catalogue No.:PA 28 0521000
Molecular Formula : C4H10NO3P
Molecular Weight : 151.1
5-(3-Aminopropyl)-4,5,6-trihydroxy-1,3,2,4,6-dioxatriphosphinane 2,4,6-trioxide
Catalogue No.:PA 28 0521001
Molecular Formula : C4H12NO8P3
Molecular Weight : 295.06
Sodium hydrogen (1-hydroxy-4-(hydroxyamino)-1-phosphonobutyl)phosphonate
Catalogue No.:PA 28 0521002
Molecular Formula : C4H12NNaO8P2
Molecular Weight : 287.08
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
